According to the
World Health Organization, there is a great disparity in the life expectancy
rate in low-income countries than in high-income countries, such as Australia, Canada,
U.S., and U.K., among others. In 2016, life expectancy was 18.1 years lower in
low-income countries (62.7 years) than in high-income countries (80.8 years).
In low-income countries, on an average, fewer than 3 out of 5 newborns are
expected to reach 70 years, and more than one-third of total deaths are among
children younger than 15 years. These premature deaths are mainly due to lower respiratory
infections, gastro-intestinal infections, acquired immunodeficiency syndrome (AIDS),
malaria, and premature birth complications.
Among the
various prevailing chronic diseases, cancer is the second-leading cause of
deaths after cardiovascular disorders, globally, which accounts for an
estimated 9.6 million deaths in 2018. Other than cancer, infectious diseases, such
as HIV/AIDS, Tuberculosis, Malaria, and HPV are also responsible for the
increasing death rates, especially in developing countries. In 2018, HIV
accounted for 770,000 deaths globally, and more than 1.7 million people were
newly infected. In 2018, there were an estimated 228 million cases of malaria
worldwide.
View BIS Report
on Digital
PCR Market
Further, private
and public companies in the market have leveraged technological advancements to
manufacture rapid diagnostic testing products, offering high efficiency and specificity,
leading to a massive scope for product commercialization and adoption. Collectively,
these instances have changed the scope of digital PCR-based solutions, shaping
it up into an inseparable part of healthcare protocols due to its miniaturized
form and high-throughput analysis of target nucleic acids at reduced cost and time.
Even though the industry is at an initial stage, increased focus on research for
the development of products by the established players in the industry for expanding
digital-PCR is expanding the market.
Comments
Post a Comment